John Gordon Freund - Net Worth and Insider Trading
John Gordon Freund Net Worth
The estimated net worth of John Gordon Freund is at least $123 Million dollars as of 2024-09-20. John Gordon Freund is the Director, 10% Owner of Collegium Pharmaceutical Inc and owns about 2,949,916 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $115 Million. John Gordon Freund is the Director of XenoPort Inc and owns about 502,486 shares of XenoPort Inc (XNPT) stock worth over $4 Million. John Gordon Freund is also the Director of Sutro Biopharma Inc and owns about 560,053 shares of Sutro Biopharma Inc (STRO) stock worth over $2 Million. Besides these, John Gordon Freund also holds SI-BONE Inc (SIBN) , Concert Pharmaceuticals Inc (CNCE) , Tetraphase Pharmaceuticals Inc (TTPH) . Details can be seen in John Gordon Freund's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Gordon Freund has not made any transactions after 2023-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Gordon Freund
John Gordon Freund Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Gordon Freund owns 10 companies in total, including SI-BONE Inc (SIBN) , Sutro Biopharma Inc (STRO) , and Collegium Pharmaceutical Inc (COLL) among others .
Click here to see the complete history of John Gordon Freund’s form 4 insider trades.
Insider Ownership Summary of John Gordon Freund
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SIBN | SI-BONE Inc | 2023-08-09 | director & 10 percent owner |
STRO | Sutro Biopharma Inc | 2020-09-18 | director & 10 percent owner |
COLL | Collegium Pharmaceutical Inc | 2022-05-19 | director |
2019-12-10 | director | ||
2014-10-21 | 10 percent owner | ||
2016-07-05 | director | ||
2015-02-20 | other: fomer 10% holder | ||
2012-05-29 | 10 percent owner | ||
2014-02-12 | 10 percent owner | ||
2009-06-17 | director |
John Gordon Freund Latest Holdings Summary
John Gordon Freund currently owns a total of 6 stocks. Among these stocks, John Gordon Freund owns 2,949,916 shares of Collegium Pharmaceutical Inc (COLL) as of May 12, 2015, with a value of $115 Million and a weighting of 93.43%. John Gordon Freund owns 502,486 shares of XenoPort Inc (XNPT) as of November 11, 2015, with a value of $4 Million and a weighting of 2.89%. John Gordon Freund also owns 560,053 shares of Sutro Biopharma Inc (STRO) as of September 18, 2020, with a value of $2 Million and a weighting of 1.79%. The other 3 stocks SI-BONE Inc (SIBN) , Concert Pharmaceuticals Inc (CNCE) , Tetraphase Pharmaceuticals Inc (TTPH) have a combined weighting of 1.89% among all his current holdings.
Latest Holdings of John Gordon Freund
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
COLL | Collegium Pharmaceutical Inc | 2015-05-12 | 2,949,916 | 38.94 | 114,869,729 |
XNPT | XenoPort Inc | 2015-11-11 | 502,486 | 7.07 | 3,552,576 |
STRO | Sutro Biopharma Inc | 2020-09-18 | 560,053 | 3.92 | 2,195,408 |
SIBN | SI-BONE Inc | 2023-08-09 | 129,734 | 15.82 | 2,052,392 |
CNCE | Concert Pharmaceuticals Inc | 2014-02-12 | 32,372 | 8.37 | 270,954 |
TTPH | Tetraphase Pharmaceuticals Inc | 2019-12-10 | 0 | 2.20 | 0 |
Holding Weightings of John Gordon Freund
John Gordon Freund Form 4 Trading Tracker
According to the SEC Form 4 filings, John Gordon Freund has made a total of 0 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years. The most-recent trade in Collegium Pharmaceutical Inc is the acquisition of 150,000 shares on May 12, 2015, which cost John Gordon Freund around $2 Million.
According to the SEC Form 4 filings, John Gordon Freund has made a total of 0 transactions in XenoPort Inc (XNPT) over the past 5 years. The most-recent trade in XenoPort Inc is the sale of 909 shares on November 11, 2015, which brought John Gordon Freund around $6,072.
According to the SEC Form 4 filings, John Gordon Freund has made a total of 3 transactions in Sutro Biopharma Inc (STRO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Sutro Biopharma Inc is the sale of 400,000 shares on September 18, 2020, which brought John Gordon Freund around $5 Million.
More details on John Gordon Freund's insider transactions can be found in the Insider Trading History of John Gordon Freund table.Insider Trading History of John Gordon Freund
- 1
John Gordon Freund Trading Performance
GuruFocus tracks the stock performance after each of John Gordon Freund's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Gordon Freund is 14.84%. GuruFocus also compares John Gordon Freund's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Gordon Freund within 3 months outperforms 9 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Gordon Freund's insider trading performs compared to the benchmark.
Performance of John Gordon Freund
John Gordon Freund Ownership Network
John Gordon Freund Owned Company Details
What does SI-BONE Inc do?
Who are the key executives at SI-BONE Inc?
John Gordon Freund is the director & 10 percent owner of SI-BONE Inc. Other key executives at SI-BONE Inc include Chief Financial Officer Anshul Maheshwari , Chief Commercial Officer Anthony J Recupero , and Chief Financial Officer Laura Francis .
SI-BONE Inc (SIBN) Insider Trades Summary
Over the past 18 months, John Gordon Freund made 1 insider transaction in SI-BONE Inc (SIBN) with a net sale of 30,000. Other recent insider transactions involving SI-BONE Inc (SIBN) include a net sale of 361,979 shares made by Jeffrey W Dunn , a net sale of 56,302 shares made by Anthony J Recupero , and a net sale of 27,556 shares made by Anshul Maheshwari .
In summary, during the past 3 months, insiders sold 29,252 shares of SI-BONE Inc (SIBN) in total and bought 0 shares, with a net sale of 29,252 shares. During the past 18 months, 520,387 shares of SI-BONE Inc (SIBN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 520,387 shares.
SI-BONE Inc (SIBN)'s detailed insider trading history can be found in Insider Trading Tracker table.
SI-BONE Inc Insider Transactions
John Gordon Freund Mailing Address
Above is the net worth, insider trading, and ownership report for John Gordon Freund. You might contact John Gordon Freund via mailing address: 125 University Ave., C/o Skyline Ventures, Palo Alto Ca 94301.